Viewing nowBearyl Tablet 4 mg (Glimepiride)
Glimepiride 4mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

MFDS item code 201906350 · Approved 2019.09.06 · Insurance code 694002580
Improvement of blood glucose control in type 2 diabetes mellitus
This medication is used in conjunction with dietary control and exercise therapy to help manage blood sugar levels in patients with type 2 diabetes. It can be administered alone and may also be used alongside insulin if adequate blood sugar control is not achievable with oral hypoglycemic agents alone. Additionally, if blood sugar control is insufficient with sulfonylureas or metformin, this medication may be used in combination with metformin. Thus, this medication effectively aids in the improvement of blood sugar control.
Adjust the dose individually for each patient. Swallow without chewing with at least 1/2 cup of water. This medicine is administered orally once daily. Take it before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose determination For patients who have not previously received medication, start treatment with glimepiride 1 mg once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, there is little additional benefit at doses above 4 mg, although some patients have achieved better metabolic control with an increase to 6 mg (or 8 mg). If treatment with 4 mg per day is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic medicine. 2) Subsequent dose adjustment As diabetes control may improve during treatment, the patient's requirement for this medicine may decrease. Therefore, dose reduction or discontinuation may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral glucose-lowering agent to this medicine There is no precise dose equivalence between this medicine and other oral glucose-lowering agents. When switching from another oral glucose-lowering agent to this medicine, it is recommended to follow the method described under Initial dose. That is, start at 1 mg once daily and adjust the dose at intervals of 1 ~ 2 weeks. The potency and duration of action of the previous medicine should be taken into consideration. 4) Dose adjustment During treatment with this medicine, blood glucose and/or urine glucose levels should be measured regularly. Regular measurement of glycated hemoglobin (HbA1c) is also recommended. In general, hypoglycemia can be promptly controlled by immediately consuming sugar. Hypoglycemia may recur even after it has been successfully treated initially during administration of a sulfonylurea. Therefore, patients should be carefully monitored. Severe hypoglycemia requires immediate treatment and follow-up by a physician and sometimes hospitalization. 2. Combination therapy 1) Combination therapy with insulin Combination therapy of this medicine with insulin is used in patients with secondary failure when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal, and initiate insulin at a low dose, increasing it approximately weekly according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. Insulin doses should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, addition of metformin may be considered. Clinical information has been published on combination therapy of metformin with other sulfonylureas, such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this medicine is administered in combination with metformin, the desired blood glucose level may be achieved by adjusting the dose of each medicine. However, efforts should be made to identify the minimum effective dose of each medicine for blood glucose control. There is a risk of hypoglycemia when this medicine is administered with metformin, and the risk may increase. Appropriate caution should be exercised.
This medication should not be used in patients with insulin-dependent diabetes, diabetic ketoacidosis, or those in a coma. Patients who are allergic to this medication or its components, including sulfonylureas or sulfonamides, should not use it. There is no experience of use in patients with severely impaired liver or kidney function, and it is recommended that these patients switch to insulin therapy. Women who are pregnant or may become pregnant, as well as nursing mothers, should not take this medication. Patients with severe infections, before or after surgery, or with severe trauma may require insulin therapy. Patients with gastrointestinal disorders such as diarrhea or vomiting may have an increased risk of hypoglycemia due to inadequate food absorption. This medication contains lactose and should not be administered to patients with lactose intolerance or certain genetic metabolic disorders. During the initial week of administration, there is a higher risk of hypoglycemia, so blood sugar levels should be monitored closely. This risk is particularly greater for the elderly, those with poor nutritional status or those who skip meals, patients with imbalanced exercise and carbohydrate intake, and those who frequently consume alcohol. Patients with weakened liver or kidney function may also be more sensitive to this medication, requiring caution. Additionally, dysfunction of the thyroid, pituitary, or adrenal glands may impact blood sugar control. There may be changes in blood sugar levels if this medication is overdosed or taken in combination with other medications. If symptoms of hypoglycemia occur, the doctor or pharmacist should be informed immediately, and dose adjustments may be necessary. The most common side effect of this medication is hypoglycemia, which can manifest as headaches, extreme hunger, nausea, fatigue, confusion, drowsiness, and loss of consciousness. Symptoms of hypoglycemia may also present as adrenergic responses such as sweating, cold skin, anxiety, and palpitations. Gastrointestinal disturbances such as visual disturbances, nausea, vomiting, abdominal pain, and diarrhea can also occur. Severe side effects such as liver dysfunction or decreased blood cell counts have been rarely reported, so any abnormal symptoms should be reported to a healthcare professional immediately. Allergic reactions such as hives, rash, difficulty breathing, and shock may occur; if these symptoms arise, the medication should be discontinued and medical attention sought urgently. This medication must be taken regularly alongside dietary and exercise therapies for optimal effectiveness, and it is crucial to consistently monitor blood sugar control. In the event of hypoglycemia, sugar or sweetened drinks should be consumed quickly to elevate blood sugar levels, as artificial sweeteners will not be effective. Under stress, during surgery, or with infections, blood sugar control may become difficult, necessitating a temporary switch to insulin therapy. Close monitoring for hypoglycemia and hyperglycemia is essential, especially during initial administration or dose changes, and caution is advised when driving or operating machinery. This medication is metabolized in the liver, so there may be interactions with certain medications; therefore, it is essential to inform the doctor or pharmacist if currently taking other medications. Particularly, changes in blood sugar levels may occur when used in combination with beta-blockers, antibiotics, anticoagulants, and corticosteroids. Pregnant or nursing mothers should avoid using this medication due to potential harm to the fetus or newborn and should switch to insulin treatment if necessary. Safety and efficacy have not been established in children under 18 years of age. In the elderly, renal function may decline, necessitating careful dosage adjustments. In the case of overdose, severe hypoglycemia may occur, requiring immediate medical treatment, and measures such as inducing vomiting or administering activated charcoal and glucose infusion may be needed. This medication should be stored out of the reach of children and kept in its original container for safety.
Hypoglycemia, headache, severe hunger, nausea, vomiting, fatigue, sleep, sleep disorders, anxiety, aggressiveness, decreased concentration, reduced agility or motivation, depression, confusion, speech abnormalities, aphasia, visual impairment, tremors, incomplete paralysis, sensory disturbances, dizziness, weakness, loss of self-control, transient mental confusion, cerebral convulsions, drowsiness, loss of consciousness, coma, shallow breathing, bradycardia, sweating, cool and moist skin, tachycardia, hypertension, palpitations, angina, deep vein thrombosis, blurred vision, feeling of fullness or pressure in the upper abdomen, abdominal pain, diarrhea, increased liver enzymes, liver dysfunction, bile secretion disorders, jaundice, hepatitis, thrombocytopenia, leukopenia, hemolytic anemia, erythrocytopenia, granulocytopenia, agranulocytosis, pancytopenia, itching, urticaria, rash, dyspnea, hypotension, shock, anaphylaxis, angioedema, Stevens-Johnson syndrome, allergic vasculitis, photosensitive reactions of the skin, decreased serum sodium concentration, taste disturbances, hair loss, weight gain, dizziness, liver dysfunction, abdominal pain, arthralgia, indigestion, facial edema, erectile dysfunction, facial flushing, gastritis
Not everyone experiences these, and they can vary from person to person.
This medication must be stored in a tightly sealed container to prevent exposure to air or moisture, and it is safe to keep it at room temperature between 1 and 30 degrees Celsius. Storing it this way will maintain the medication's efficacy and prevent degradation.
Light blue rectangular tablet
For domestic use - 30 tablets/bottle, For domestic use - 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowGlimepiride 4mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

Glimepiride 1mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 4mg
Tablet · Prescription medication
(Hanmi Pharmaceutical Co., Ltd.)

Glimepiride 2mg
Tablet · Prescription medication
Seoul Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
IYun Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.